Medidata Study Experience
-
Unlock Peak Performance: AI-Powered Study Start-Up And Execution
10/14/2025
In part two of our webinar series, speakers delve into how artificial intelligence is reshaping every stage of the clinical trial journey — from designing smarter, more feasible protocols to streamlining study start-up and execution.
-
Intelligent Clinical Trials: Enhance Study Design And Live Forecasting
8/29/2025
The integration of standardized, regulatory-grade clinical trial data has become central to advancing trial design and execution.
-
Medidata CTMS - On Time. On Budget. In Sync
8/4/2025
Learn how you can build support for both sponsor-led and CRO-managed trials with seamless execution, transparency, and control.
-
Synthetic Control ArmĀ®: The Smart External Control Arm Solution
7/21/2025
Discover how an external control arm can help you generate rigorous evidence, accelerate decisions, and keep your trial on track when a concurrent control isn’t feasible.
-
Why Customers Are Switching To Medidata CTMS And eTMF
7/17/2025
Discover a CTMS that leads the market with top rankings and offers unmatched integration, automation, and user experience for faster, more efficient clinical trial execution.
-
A New Approach To Dynamic Clinical Oversight With Centralized Insights
7/10/2025
RBQM is transforming clinical trial oversight. By automating protocol digitalization, site selection, and risk assessments 360° Monitoring enables the proactive identification of CtQ factors.
-
Achieve Financial Management Success With Rave CTFM
6/17/2025
Achieve operational and resource planning success for your clinical trial with the help of Rave Clinical Trial Financial Management (CTFM).
-
Medidata CTMS Leads The Industry
5/16/2025
The 2024 Everest Group PEAK Matrix assessment has named Medidata CTMS the leading Clinical Trial Management System (CTMS).
-
Accelerate Your Operations With Smarter Trial Management
1/22/2025
Learn about a cloud-based solution that centralizes clinical and operational data to improve the efficiency and oversight of clinical trials.
-
FDA Draft Guidance On Diversity Action Plan Requirements
10/24/2024
Explore new drafted guidance under FDORA that substantiates the mandate of a Diversity Action Plan (DAP) for late-stage trial protocol submissions.